BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $29.00
BridgeBio Pharma (NASDAQ:BBIO – Get Rating) had its price target boosted by Mizuho from $23.00 to $29.00 in a research note issued to investors on Monday, The Fly reports. A number of other equities research analysts have also recently commented on BBIO. The Goldman Sachs Group raised their price target on BridgeBio Pharma from $20.00 […]